HK Stock MarketDetailed Quotes

HM INTL HLDGS (08416)

Watchlist
  • 0.105
  • 0.0000.00%
Market Closed Apr 30 09:00 CST
44.25MMarket Cap5.53P/E (TTM)

HM INTL HLDGS (08416) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
-16.73%132.31M
-15.73%78.47M
-11.05%158.89M
-5.37%93.11M
-6.13%178.62M
-4.24%144.85M
-2.29%98.39M
-10.06%26.85M
10.12%190.29M
15.42%151.27M
Operating income
-16.73%132.31M
-15.73%78.47M
-11.05%158.89M
-5.37%93.11M
-6.13%178.62M
-4.24%144.85M
-2.29%98.39M
-10.06%26.85M
10.12%190.29M
15.42%151.27M
Cost of sales
22.21%-79.36M
16.50%-46.01M
11.96%-102.01M
9.70%-55.1M
4.83%-115.87M
5.04%-86.91M
-2.32%-61.02M
1.40%-21.16M
-11.76%-121.75M
-16.79%-91.52M
Operating expenses
22.21%-79.36M
16.50%-46.01M
11.96%-102.01M
9.70%-55.1M
4.83%-115.87M
5.04%-86.91M
-2.32%-61.02M
1.40%-21.16M
-11.76%-121.75M
-16.79%-91.52M
Gross profit
-6.89%52.96M
-14.61%32.45M
-9.37%56.88M
1.71%38.01M
-8.43%62.76M
-3.02%57.94M
-9.00%37.37M
-32.22%5.69M
7.32%68.54M
13.37%59.74M
Selling expenses
13.34%-9.08M
2.34%-5.59M
12.72%-10.47M
5.45%-5.73M
16.76%-12M
16.13%-9.21M
15.02%-6.06M
7.64%-2.72M
-0.73%-14.41M
-4.06%-10.98M
Administrative expenses
14.30%-46.19M
17.37%-22.26M
-11.27%-53.89M
-10.80%-26.93M
-1.25%-48.43M
-10.23%-37.02M
-14.34%-24.31M
-7.23%-11.37M
-10.21%-47.83M
-8.92%-33.59M
Special items of operating profit
804.45%11.4M
688.47%3.56M
-135.51%-1.62M
-69.55%451K
248.32%4.56M
-74.46%721K
-36.49%1.48M
1,681.13%944K
170.21%1.31M
976.71%2.82M
Operating profit
199.92%9.1M
40.77%8.16M
-232.25%-9.1M
-31.68%5.8M
-9.41%6.88M
-30.96%12.43M
-43.47%8.49M
-46.07%-7.46M
77.22%7.6M
63.86%18M
Financing cost
4.37%-919K
-20.54%-493K
-38.27%-961K
-7.92%-409K
0.14%-695K
-21.95%-550K
-36.33%-379K
-11.29%-207K
58.67%-696K
67.76%-451K
Share of profits of associates
----
----
----
----
111.21%60K
-74.43%78K
1,322.22%330K
61.15%224K
-147.43%-535K
-35.92%305K
Share of profit from joint venture company
----
----
----
----
-70.40%296K
-76.60%296K
-62.86%296K
-432.35%-181K
880.39%1M
--1.27M
Earning before tax
181.25%8.18M
42.31%7.67M
-253.78%-10.07M
-38.29%5.39M
-11.17%6.55M
-35.92%12.25M
-43.67%8.73M
-46.95%-7.63M
92.18%7.37M
90.01%19.12M
Tax
-347.74%-384K
-246.93%-407K
354.10%155K
162.95%277K
73.48%-61K
92.41%-76K
28.92%-440K
62.26%-20K
-367.44%-230K
-81.01%-1M
After-tax profit from continuing operations
178.65%7.79M
28.17%7.26M
-252.84%-9.91M
-31.68%5.67M
-9.16%6.48M
-32.80%12.17M
-44.28%8.29M
-45.84%-7.65M
82.09%7.14M
90.53%18.12M
Earning after tax
178.65%7.79M
28.17%7.26M
-252.84%-9.91M
-31.68%5.67M
-9.16%6.48M
-32.80%12.17M
-44.28%8.29M
-45.84%-7.65M
82.09%7.14M
90.53%18.12M
Minority profit
98.31%-37K
-158.02%-275K
-1,100.00%-2.19M
-56.95%474K
525.71%219K
5.13%1.58M
6.69%1.1M
-55.86%-971K
-2.78%35K
614.76%1.5M
Profit attributable to shareholders
201.44%7.83M
45.17%7.54M
-223.22%-7.72M
-27.81%5.19M
-11.80%6.27M
-36.23%10.6M
-48.08%7.19M
-44.49%-6.68M
82.88%7.1M
78.69%16.62M
Basic earnings per share
198.42%0.0187
45.53%0.0179
-221.79%-0.019
-30.51%0.0123
-12.36%0.0156
-37.83%0.0258
-48.84%0.0177
-43.97%-0.0167
83.51%0.0178
78.88%0.0415
Diluted earnings per share
198.42%0.0187
45.53%0.0179
-225.00%-0.019
-30.51%0.0123
-14.61%0.0152
-37.83%0.0258
-48.84%0.0177
-43.97%-0.0167
83.51%0.0178
78.88%0.0415
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
--
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover -16.73%132.31M-15.73%78.47M-11.05%158.89M-5.37%93.11M-6.13%178.62M-4.24%144.85M-2.29%98.39M-10.06%26.85M10.12%190.29M15.42%151.27M
Operating income -16.73%132.31M-15.73%78.47M-11.05%158.89M-5.37%93.11M-6.13%178.62M-4.24%144.85M-2.29%98.39M-10.06%26.85M10.12%190.29M15.42%151.27M
Cost of sales 22.21%-79.36M16.50%-46.01M11.96%-102.01M9.70%-55.1M4.83%-115.87M5.04%-86.91M-2.32%-61.02M1.40%-21.16M-11.76%-121.75M-16.79%-91.52M
Operating expenses 22.21%-79.36M16.50%-46.01M11.96%-102.01M9.70%-55.1M4.83%-115.87M5.04%-86.91M-2.32%-61.02M1.40%-21.16M-11.76%-121.75M-16.79%-91.52M
Gross profit -6.89%52.96M-14.61%32.45M-9.37%56.88M1.71%38.01M-8.43%62.76M-3.02%57.94M-9.00%37.37M-32.22%5.69M7.32%68.54M13.37%59.74M
Selling expenses 13.34%-9.08M2.34%-5.59M12.72%-10.47M5.45%-5.73M16.76%-12M16.13%-9.21M15.02%-6.06M7.64%-2.72M-0.73%-14.41M-4.06%-10.98M
Administrative expenses 14.30%-46.19M17.37%-22.26M-11.27%-53.89M-10.80%-26.93M-1.25%-48.43M-10.23%-37.02M-14.34%-24.31M-7.23%-11.37M-10.21%-47.83M-8.92%-33.59M
Special items of operating profit 804.45%11.4M688.47%3.56M-135.51%-1.62M-69.55%451K248.32%4.56M-74.46%721K-36.49%1.48M1,681.13%944K170.21%1.31M976.71%2.82M
Operating profit 199.92%9.1M40.77%8.16M-232.25%-9.1M-31.68%5.8M-9.41%6.88M-30.96%12.43M-43.47%8.49M-46.07%-7.46M77.22%7.6M63.86%18M
Financing cost 4.37%-919K-20.54%-493K-38.27%-961K-7.92%-409K0.14%-695K-21.95%-550K-36.33%-379K-11.29%-207K58.67%-696K67.76%-451K
Share of profits of associates ----------------111.21%60K-74.43%78K1,322.22%330K61.15%224K-147.43%-535K-35.92%305K
Share of profit from joint venture company -----------------70.40%296K-76.60%296K-62.86%296K-432.35%-181K880.39%1M--1.27M
Earning before tax 181.25%8.18M42.31%7.67M-253.78%-10.07M-38.29%5.39M-11.17%6.55M-35.92%12.25M-43.67%8.73M-46.95%-7.63M92.18%7.37M90.01%19.12M
Tax -347.74%-384K-246.93%-407K354.10%155K162.95%277K73.48%-61K92.41%-76K28.92%-440K62.26%-20K-367.44%-230K-81.01%-1M
After-tax profit from continuing operations 178.65%7.79M28.17%7.26M-252.84%-9.91M-31.68%5.67M-9.16%6.48M-32.80%12.17M-44.28%8.29M-45.84%-7.65M82.09%7.14M90.53%18.12M
Earning after tax 178.65%7.79M28.17%7.26M-252.84%-9.91M-31.68%5.67M-9.16%6.48M-32.80%12.17M-44.28%8.29M-45.84%-7.65M82.09%7.14M90.53%18.12M
Minority profit 98.31%-37K-158.02%-275K-1,100.00%-2.19M-56.95%474K525.71%219K5.13%1.58M6.69%1.1M-55.86%-971K-2.78%35K614.76%1.5M
Profit attributable to shareholders 201.44%7.83M45.17%7.54M-223.22%-7.72M-27.81%5.19M-11.80%6.27M-36.23%10.6M-48.08%7.19M-44.49%-6.68M82.88%7.1M78.69%16.62M
Basic earnings per share 198.42%0.018745.53%0.0179-221.79%-0.019-30.51%0.0123-12.36%0.0156-37.83%0.0258-48.84%0.0177-43.97%-0.016783.51%0.017878.88%0.0415
Diluted earnings per share 198.42%0.018745.53%0.0179-225.00%-0.019-30.51%0.0123-14.61%0.0152-37.83%0.0258-48.84%0.0177-43.97%-0.016783.51%0.017878.88%0.0415
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.------National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More